LY
Insider
Laith L Yaldoo
DirectorLaith L Yaldoo (Director) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in ZIVO. Across 2 priced purchase filings, the average 21-session return was +14.9% from execution and -1.8% from disclosure (delay-adjusted; derived). The largest single filing was $245K of ZIVO (15,322 sh × $15.99, as filed), executed Sep 30 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+14.9%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-1.8%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells · 1 late
Median delay
37d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$371K
shares × price, as filed
Last traded
Sep 30 2025
Filed Oct 2 2025
Volume by month
Buys $371K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Most traded names
ZIVO
ZIVO
2 buys · 0 sells
2 filings
Recent filings
ZIVOPURCHASE
Zivo Bioscience, Inc.
View filing →
$245K15,322 sh × $15.99
Exec Sep 30 2025
Filed Oct 2 2025 · 9:19 PM ET ZIVOPURCHASE Zivo Bioscience, Inc. View filing → $126K
7,200 sh × $17.53
Exec Jan 22 2025
Filed Apr 4 2025 · 5:30 PM ET †